André Baruchel

9.9k total citations
45 papers, 1.7k citations indexed

About

André Baruchel is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, André Baruchel has authored 45 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 16 papers in Oncology and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in André Baruchel's work include Acute Lymphoblastic Leukemia research (13 papers), CAR-T cell therapy research (12 papers) and Acute Myeloid Leukemia Research (10 papers). André Baruchel is often cited by papers focused on Acute Lymphoblastic Leukemia research (13 papers), CAR-T cell therapy research (12 papers) and Acute Myeloid Leukemia Research (10 papers). André Baruchel collaborates with scholars based in France, Netherlands and Germany. André Baruchel's co-authors include Hervé Dombret, Jean Soulier, Emmanuelle Clappier, Jean‐Michel Cayuela, Nicolas Boissel, François Sigaux, Marı́a L. Toribio, Marina García-Peydró, Armelle Régnault and François Doz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

André Baruchel

44 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
André Baruchel France 22 757 650 516 325 306 45 1.7k
Blythe Thomson United States 15 538 0.7× 375 0.6× 596 1.2× 230 0.7× 329 1.1× 39 1.7k
Martha G. Sensel United States 24 1.3k 1.7× 1.7k 2.6× 603 1.2× 787 2.4× 438 1.4× 42 2.8k
Mitchell Sabloff Canada 21 955 1.3× 336 0.5× 294 0.6× 125 0.4× 307 1.0× 68 1.5k
Vita J. Land United States 27 803 1.1× 1.1k 1.8× 443 0.9× 725 2.2× 515 1.7× 61 2.4k
J T Sandlund United States 20 1.1k 1.5× 1.6k 2.4× 459 0.9× 872 2.7× 446 1.5× 31 2.4k
Anna Butturini United States 17 432 0.6× 373 0.6× 258 0.5× 279 0.9× 301 1.0× 48 1.1k
FR Davey United States 14 1.1k 1.4× 722 1.1× 372 0.7× 166 0.5× 266 0.9× 32 1.6k
S B Murphy United States 21 687 0.9× 1.1k 1.7× 253 0.5× 545 1.7× 458 1.5× 32 1.9k
Judith Landman‐Parker France 17 262 0.3× 321 0.5× 510 1.0× 110 0.3× 434 1.4× 47 1.5k
Luciana Annino Italy 27 1.1k 1.4× 929 1.4× 340 0.7× 213 0.7× 372 1.2× 75 2.0k

Countries citing papers authored by André Baruchel

Since Specialization
Citations

This map shows the geographic impact of André Baruchel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Baruchel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Baruchel more than expected).

Fields of papers citing papers by André Baruchel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Baruchel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Baruchel. The network helps show where André Baruchel may publish in the future.

Co-authorship network of co-authors of André Baruchel

This figure shows the co-authorship network connecting the top 25 collaborators of André Baruchel. A scholar is included among the top collaborators of André Baruchel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Baruchel. André Baruchel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chonat, Satheesh, Alexander Kulagin, Alexey Maschan, et al.. (2024). Pharmacokinetics, pharmacodynamics, efficacy, and safety of ravulizumab in pediatric paroxysmal nocturnal hemoglobinuria. Blood Advances. 8(11). 2813–2824. 5 indexed citations
2.
Dourthe, Marie-Émilie, Guillaume P. Andrieu, Mathieu Simonin, et al.. (2023). Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALL. HemaSphere. 7(4). e871–e871.
3.
Buechner, Jochen, Ignazio Caruana, Annette Künkele, et al.. (2022). Chimeric Antigen Receptor T-Cell Therapy in Paediatric B-Cell Precursor Acute Lymphoblastic Leukaemia: Curative Treatment Option or Bridge to Transplant?. Frontiers in Pediatrics. 9. 784024–784024. 16 indexed citations
4.
Valade, Sandrine, Michaël Darmon, Lara Zafrani, et al.. (2022). The use of ICU resources in CAR-T cell recipients: a hospital-wide study. Annals of Intensive Care. 12(1). 75–75. 10 indexed citations
5.
Beauvais, David, Emmanuel Bachy, André Baruchel, et al.. (2021). Éligibilité des patients aux cellules CAR-T : avis d’experts proposé par la SFGM-TC. Bulletin du Cancer. 108(7-8). 725–729. 2 indexed citations
6.
7.
Dourthe, Marie-Émilie & André Baruchel. (2018). CAR-T cells et leucémies aiguës lymphoblastiques de l’enfant et de l’adulte. Bulletin de l Académie Nationale de Médecine. 202(7). 1441–1451. 1 indexed citations
8.
Dourthe, Marie-Émilie, Karima Yakouben, Delphine Chaillou, et al.. (2018). CAR-T cells : indications actuelles en pédiatrie et perspectives de développement. Bulletin du Cancer. 105. S147–S157. 3 indexed citations
9.
Pearson, Andrew D.J., Stefan M. Pfister, André Baruchel, et al.. (2017). From class waivers to precision medicine in paediatric oncology. The Lancet Oncology. 18(7). e394–e404. 36 indexed citations
10.
Orbach, Daniel, Sabine Sarnacki, Hervé J. Brisse, et al.. (2013). Neonatal cancer. The Lancet Oncology. 14(13). e609–e620. 62 indexed citations
11.
Paolettí, Xavier, Birgit Geoerger, François Doz, et al.. (2013). A comparative analysis of paediatric dose-finding trials of molecularly targeted agent with adults’ trials. European Journal of Cancer. 49(10). 2392–2402. 44 indexed citations
12.
Dalle, Jean‐Hugues, Corinne Alberti, Brigitte Lescoeur, et al.. (2012). Malignant and benign thyroid nodules after total body irradiation preceding hematopoietic cell transplantation during childhood. European Journal of Endocrinology. 167(2). 225–233. 25 indexed citations
13.
14.
Kosmider, Olivier, Bruno Cassinat, Aline Renneville, et al.. (2010). Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia. British Journal of Haematology. 151(5). 460–468. 40 indexed citations
15.
Pédron, Béatrice, Karima Yakouben, Valérie Guérin, et al.. (2006). HLA Alleles and Haplotypes in French North African Immigrants. Human Immunology. 67(7). 540–550. 22 indexed citations
16.
Poirot, Catherine, Hélène Martelli, Catherine Genestie, et al.. (2006). Feasibility of ovarian tissue cryopreservation for prepubertal females with cancer. Pediatric Blood & Cancer. 49(1). 74–78. 86 indexed citations
17.
Clappier, Emmanuelle, Wendy Cuccuini, J M Cayuela, et al.. (2005). Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias. Leukemia. 20(1). 82–86. 40 indexed citations
18.
Robin, Marie, Philippe Guardiola, Hervé Dombret, et al.. (2003). Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality. Bone Marrow Transplantation. 31(10). 877–887. 25 indexed citations
19.
Raz, Tal, Valentina Labay, Raymonde Szargel, et al.. (2000). The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia geneSLC19A2 of eight families. Human Mutation. 16(1). 37–42. 48 indexed citations
20.
Brice, Pauline, Réda Bouabdallah, Philippe Moreau, et al.. (1997). Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin’s disease: analysis of 280 patients from the French registry. Bone Marrow Transplantation. 20(1). 21–26. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Blythe Thomson Breakdown of academic impact, for papers by Martha G. Sensel Breakdown of academic impact, for papers by Mitchell Sabloff Breakdown of academic impact, for papers by Vita J. Land Breakdown of academic impact, for papers by J T Sandlund Breakdown of academic impact, for papers by Anna Butturini Breakdown of academic impact, for papers by FR Davey Breakdown of academic impact, for papers by S B Murphy Breakdown of academic impact, for papers by Judith Landman‐Parker Breakdown of academic impact, for papers by Luciana Annino
Rankless by CCL
2026